CRNI Parenteral Nutrition Administration 2 — Questions and Answers

Question 1: What is the maximum recommended rate for initiating total parenteral nutrition in an adult patient?

Full rate immediately
25-50% of goal rate for the first 24 hours (Correct answer)
10 mL/hr for the first 48 hours
Match the rate to the patient's oral intake

Correct answer: 25-50% of goal rate for the first 24 hours

TPN should be initiated at 25-50% of the goal rate and advanced gradually over 24-48 hours to prevent metabolic complications including refeeding syndrome.

Initiating TPN at reduced rates (25-50% of goal) and advancing over 24-48 hours allows the body to adapt to the increased glucose and nutrient load. This is particularly critical in malnourished patients at risk for refeeding syndrome - a potentially fatal condition caused by rapid shifts in electrolytes (phosphorus, potassium, magnesium) as the body transitions from catabolic to anabolic metabolism. Insulin secretion surges in response to glucose, driving electrolytes intracellularly. The CRNI must monitor blood glucose every 4-6 hours during initiation, check electrolytes (especially phosphorus, potassium, magnesium) daily, and watch for signs of refeeding syndrome including cardiac arrhythmias, respiratory failure, and edema.

Question 2: Which filter size is required for 3-in-1 (total nutrient admixture) parenteral nutrition containing lipids?

0.22-micron filter
1.2-micron filter (Correct answer)
5-micron filter
No filter is required

Correct answer: 1.2-micron filter

A 1.2-micron filter is required for 3-in-1 TNA solutions because lipid emulsion particles (0.4-0.5 microns) cannot pass through a 0.22-micron filter.

Total nutrient admixtures (TNAs or 3-in-1 solutions) combine dextrose, amino acids, and lipids in a single bag. Lipid emulsion particles range from 0.4-0.5 microns, which cannot pass through a standard 0.22-micron filter - it would trap the lipids and occlude the filter. A 1.2-micron filter allows lipid particles to pass while still filtering bacteria, fungi, and particulate matter. For 2-in-1 solutions (dextrose and amino acids only, with lipids piggybacked separately), the amino acid/dextrose component uses a 0.22-micron filter, and the lipid line uses a 1.2-micron filter. The CRNI must verify the correct filter type before initiating any PN infusion.

Question 3: A patient's TPN is abruptly discontinued. What is the immediate nursing concern?

Fluid overload
Rebound hypoglycemia (Correct answer)
Hypernatremia
Metabolic alkalosis

Correct answer: Rebound hypoglycemia

Abrupt TPN discontinuation can cause rebound hypoglycemia because the pancreas continues producing elevated insulin levels in response to the sudden drop in glucose infusion.

During TPN administration, the pancreas increases insulin production to manage the high glucose load. When TPN is abruptly stopped, endogenous insulin levels remain elevated while the exogenous glucose source is removed, causing rebound hypoglycemia. Symptoms include diaphoresis, tremors, tachycardia, confusion, and potentially seizures. To prevent this, TPN should be tapered gradually (reduce rate by 50% for 1-2 hours before discontinuation) or a 10% dextrose solution infused at the same rate temporarily. The CRNI should monitor blood glucose every 30-60 minutes after TPN discontinuation and have IV dextrose readily available for emergent hypoglycemia management.

Question 4: What electrolyte must be closely monitored during the first 72 hours of TPN initiation in a malnourished patient?

Sodium
Phosphorus (Correct answer)
Chloride
Bicarbonate

Correct answer: Phosphorus

Phosphorus is the most critically affected electrolyte in refeeding syndrome, as insulin-driven cellular uptake can cause severe hypophosphatemia leading to respiratory and cardiac failure.

Hypophosphatemia is the hallmark of refeeding syndrome and the most dangerous electrolyte disturbance during TPN initiation in malnourished patients. When glucose is reintroduced, insulin secretion increases, driving phosphorus (along with potassium and magnesium) from the extracellular space into cells for energy metabolism (ATP production requires phosphorus). Severe hypophosphatemia (less than 1.0 mg/dL) causes: respiratory failure (diaphragm weakness), cardiac dysfunction (impaired contractility, arrhythmias), rhabdomyolysis, hemolytic anemia, and neurological dysfunction. The CRNI must monitor phosphorus levels at least daily (more frequently in high-risk patients) during the first 72 hours and ensure adequate phosphorus supplementation in the TPN or separately.

Question 5: Why must parenteral nutrition solutions be administered through a dedicated lumen?

To maintain accurate calorie delivery records
To prevent contamination, incompatibilities, and interruptions that affect glucose delivery (Correct answer)
Because PN solutions are too viscous for shared lumens
It is a preference, not a requirement

Correct answer: To prevent contamination, incompatibilities, and interruptions that affect glucose delivery

A dedicated lumen prevents microbial contamination from multiple access points, drug incompatibilities, and infusion interruptions that could cause blood glucose instability.

Dedicating a catheter lumen exclusively to PN administration addresses multiple safety concerns: 1) Infection prevention - PN is an excellent microbial growth medium, and each hub access increases contamination risk; 2) Drug incompatibilities - many medications are incompatible with PN components, causing precipitation, lipid destabilization, or drug inactivation; 3) Metabolic stability - interrupting PN for medication administration or blood sampling causes fluctuations in glucose delivery, leading to hypo- or hyperglycemia. The dedicated lumen should be clearly labeled, and nursing staff must be educated that no other infusions, medications, or blood draws should occur through this lumen.

Question 6: What is the maximum hang time for a lipid-containing parenteral nutrition solution?

12 hours
24 hours (Correct answer)
48 hours
72 hours

Correct answer: 24 hours

Lipid-containing PN solutions (3-in-1 TNA) must be infused within 24 hours to minimize microbial growth risk in the lipid-rich medium.

The CDC and INS guidelines specify that lipid-containing parenteral nutrition (3-in-1 TNA) must be infused within 24 hours from the time the infusion is started. Lipid emulsions provide an excellent growth medium for bacteria and fungi, particularly Candida species and gram-negative bacilli. Separate lipid infusions (IV fat emulsions piggybacked into the line) have an even shorter hang time - 12 hours per AABB guidelines. The 2-in-1 PN solution (dextrose/amino acids without lipids) can hang for 24 hours. These time limits assume the solution was properly compounded and stored. PN solutions should be refrigerated until 1 hour before infusion and inspected for particulate matter, color changes, or lipid cracking before administration.

CRNI Parenteral Nutrition Administration 2

What is the maximum recommended rate for initiating total parenteral nutrition in an adult patient?